Henry Schein, Inc. $HSIC Stock Position Decreased by Swiss National Bank

Swiss National Bank reduced its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 32.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 241,600 shares of the company's stock after selling 116,300 shares during the quarter. Swiss National Bank owned 0.20% of Henry Schein worth $16,547,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Investment Management Corp VA ADV acquired a new position in shares of Henry Schein during the fourth quarter worth $32,000. Rakuten Securities Inc. acquired a new position in shares of Henry Schein during the first quarter worth $34,000. Whittier Trust Co. lifted its position in shares of Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after purchasing an additional 700 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares in the last quarter. Finally, Allworth Financial LP lifted its position in shares of Henry Schein by 24.5% during the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after purchasing an additional 232 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on HSIC shares. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 6th. Robert W. Baird reaffirmed a "neutral" rating and issued a $72.00 price target (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Barrington Research cut their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a report on Wednesday, August 6th. JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a report on Thursday, August 7th. Finally, Wells Fargo & Company cut their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Nine equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $75.58.

Henry Schein Price Performance

HSIC traded down $0.13 on Monday, reaching $67.71. The company had a trading volume of 363,406 shares, compared to its average volume of 1,767,499. The company has a fifty day moving average of $70.81 and a 200-day moving average of $70.72. The company has a market capitalization of $8.21 billion, a P/E ratio of 21.84, a PEG ratio of 2.24 and a beta of 0.81. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The business had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same period in the prior year, the firm earned $1.23 EPS. The business's revenue for the quarter was up 3.3% on a year-over-year basis. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.